stem cell research

The GATOR NATION Source

for University of Florida News, Sports & Everything Gator Shopping

Site Index

Privacy / Legal / Disclaimer

Other Links

Disclaimer: This site is in no way affiliated with the University of Florida, the University
of Florida Athletic Association, or any sponsor or organization associated with UAA.

Advertising

The GATOR NATION Source

gatorsUF.com

110 Coliseum Crossing #316

Hampton, VA 23666

(757)-788-8791

Gator

Shopping

Credited News Sources: gainesvillesun.com, ufl.edu, alligator.org,
gatorsports.com, jacksonville.com, tbo.com, orlandosentinel.com, miami.com,
alligatorsports.org

News

Quick Links

The GATOR NATION Source

The GATOR NATION Source

About Us

[Home]

Alumni Services

[continued below]

Credited Source: ufl.edu 1/17/06

[UF News Home]

Your all in one source for everything Gator! - The GATOR NATION Source

Network scientists met last week to discuss the initial study protocols they�ll pursue from a pool of 10 submitted during
the grant application process. Studies will test whether various cell therapies can improve the heart�s plumbing by helping
to repair blood vessels or form new ones and strengthen the heart muscle to improve its ability to pump efficiently.

�In the United States we have had difficulty amassing the numbers of patients and also bringing together the multiple
disciplines required to perform stem cell therapy at one table to be able to have large enough trials to prove the worthiness
of cell therapy in cardiovascular diseases,� said Dr. Chris Cogle, an assistant professor of medicine at UF�s College of
Medicine who has expertise in stem cells and bone marrow transplantation. �This is the raison d�etre of the network, to
amass the resources, bring the necessary people to the table and recruit patients who need this help to be able to
complete these trials and answer whether or not cell therapy can help prevent heart disease or protect patients who have
it.

�We may have new options for patients whose cardiologists might have told them there�s nothing else they can do,� he
said.

Projects likely will involve the use of stem cells obtained from a patient�s own bone marrow or peripheral veins � or even
from the heart itself � and will incorporate new strategies for cell delivery to the heart and techniques for screening and
localizing transplanted cells. In some studies the cells may be treated to enhance their function before they are returned
to the body. For example, UF investigators have found that exposing these cells to nitric oxide, low oxygen levels, low
temperatures or even gene therapy enhances their ability to restore function in animal models. Methods of delivering the
cells to the blood vessels or directly into scarred heart muscle also will be tested.

UF scientists also have proposed one study that involves extracting skeletal muscle cells from the thigh in patients with
severe heart failure who are awaiting heart transplantation. The cells would be multiplied in tissue culture and then
implanted directly into the same patient�s heart. The goal would be to determine whether the cells can strengthen a very
weakened heart and determine how long the cells survive, said Dr. Daniel Pauly, an associate professor of medicine and
director of the division of cardiovascular medicine�s molecular cardiology and genetics section at UF�s College of
Medicine.

Researchers will include experts in various disciplines, such as hematology, nephrology, radiology, stem cell biology,
cardiovascular medicine, pediatric cardiology and cardiothoracic surgery. They will work closely with various university
facilities to obtain and process the cells used in the research, including the bone marrow transplant unit, and the Good
Manufacturing Practices facility at the Center of Excellence for Regenerative Health Biotechnology.

The other centers are the Cleveland Clinic, the Texas Heart Institute, the
University of Minnesota and Vanderbilt University. The network's data
coordinating center will be based at the University of Texas Health Science
Center in Houston; the NHLBI project office is in Bethesda, Md.

"Most of us believe that some form of regenerative medicine will be the
future for treatment of cardiovascular disease, that it will be the next level
of care," said Dr. Carl J. Pepine, a professor and chief of cardiovascular
medicine at UF's College of Medicine and the principal investigator and
center director for the UF site.

Researchers will focus on adults with coronary artery disease, congestive
heart failure or other conditions, including diabetes, that reduce blood flow
to the heart, damaging heart muscle and hampering its ability to function
properly. As a result, the quality of life of many of these patients becomes
very poor, as they are progressively unable to participate in their usual day-
to-day activities.

"These will be patients who have already had medical therapy, bypass
surgery, angioplasty, stents or other treatment options and have not
responded to those treatments," Pepine said. "The current thinking is we
have a limited capacity to repair our hearts and blood vessels but that is
somehow defective in people who have end-stage disease.

UF News - 1/17/07

UF to research stem cell treatments for heart disease

University of Florida researchers will play a key role in a new national
network designed to study stem cell treatments in patients with
cardiovascular disease.

As part of a five-member consortium known as the Cardiovascular Cell
Therapy Research Network, UF scientists will seek to identify and test
new cell therapies to improve the structure and function of the heart and its
blood vessels. The network and its projects will be supported by a grant
from the National Heart, Lung and Blood Institute that is expected to total
$33.7 million over the next five years. Approximately $5 million will be
disbursed in 2007.

The centers will begin meeting immediately to select protocols and then
screen patients for possible entry into multiple research trials in
cardiovascular regenerative medicine set to launch early this year. The
collaboration will enable study investigators to rapidly boost sample sizes
and expedite studies that otherwise would likely take many years to
complete. At least 10 studies are planned during the funding period.

Our hope is that by providing new cells we may be able to restore the reparative process."